“OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and support. Join the conversation in the NET community here.
“Although neuroendocrine tumors have historically been considered rare, the incidence of neuroendocrine tumors has been increasing. Recent statistics suggest that the current number of people with neuroendocrine tumors exceeds 100,000 in the United States—more than the number of people with other, better known cancers like pancreatic or stomach cancer. The increase in NET diagnoses parallels improved diagnosis and treatments around the world.”
Go to full article.
If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to use our ASK Cancer Commons service.
Cancer Commons’ partner Smart Patients launched publicly today after a presentation at the TEDMED conference in Washington, DC. Smart Patients is an online discussion platform for cancer patients and their caregivers that will enable them to learn from each other and improve their care. The free website lets users share insights about personal treatment experiences, discuss breaking science, and search for clinical trials, as shown in this demo video:
Cancer Commons will be partnering with Smart Patients to bring patients’ insights to our Rapid Learning Communities. Cancer Commons’ research collaborators will be able to access anonymous insights from Smart Patients discussions. These insights will help Cancer Commons in its mission to make sure every cancer patient is treated according to what’s working best for similar patients.
Read more at our Need to Know blog or visit www.smartpatients.com.